Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 2365480)

Published in Curr Oncol on April 01, 2008

Authors

S Verma1, T Petrella, C Hamm, K Bak, M Charette, Melanoma Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care

Author Affiliations

1: The Ottawa Hospital, Ottawa, ON.

Articles cited by this

The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol (1995) 6.08

Single-agent interleukin-2 in the treatment of metastatic melanoma: a systematic review. Cancer Treat Rev (2007) 3.15

Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial. J Clin Oncol (2002) 2.52

Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial. J Clin Oncol (2002) 1.98

Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b. J Clin Oncol (1999) 1.78

Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma. Cochrane Database Syst Rev (2007) 1.43

Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group. J Clin Oncol (2005) 1.36

Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma. Ann Oncol (2006) 1.29

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Clin Oncol (1997) 1.20

Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). Br J Cancer (2001) 1.02

Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM). Br J Cancer (2002) 0.97

Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. Eur J Cancer (2003) 0.90

Articles by these authors

A mesoscale phytoplankton bloom in the polar Southern Ocean stimulated by iron fertilization. Nature (2000) 4.36

Single-agent interleukin-2 in the treatment of metastatic melanoma: a systematic review. Cancer Treat Rev (2007) 3.15

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol (1997) 2.38

CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood (1996) 2.30

Support for future physicians. CMAJ (1993) 2.03

Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study) Eur Heart J (1998) 1.95

S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem (1991) 1.66

[Double ventricular excitation in dual atrioventricular node conduction physiology: catheter ablation of the slow conduction pathway of the dual atrioventricular node]. Z Kardiol (2000) 1.66

Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction. J Cell Mol Med (2009) 1.58

Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial. Eur Heart J (2000) 1.54

Noninvasive estimation of regurgitant flow rate and volume in patients with mitral regurgitation by Doppler color mapping of accelerating flow field. J Am Coll Cardiol (1993) 1.53

Angiographic follow-up results of a randomized study on angioplasty versus bypass surgery (GABI trial). GABI Study Group. Eur Heart J (1996) 1.50

Acute coronary syndromes: diagnosis. Lancet (1999) 1.49

A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm). Br J Dermatol (2004) 1.43

Primary excision margins and sentinel lymph node biopsy in clinically node-negative melanoma of the trunk or extremities. Clin Oncol (R Coll Radiol) (2011) 1.39

High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial. Heart (2010) 1.39

Angiographic analysis of immediate and long-term results of PTCR vs. PTCA in complex lesions (COBRA study). Catheter Cardiovasc Interv (2001) 1.39

Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol (2009) 1.32

Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol (2013) 1.27

Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood (2000) 1.27

Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood (1997) 1.19

Isolated total ruptures of the anterior cruciate ligament--a clinical study with long-term follow-up of 7 years. Scand J Med Sci Sports (1999) 1.16

Genetic variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma. Virology (2012) 1.16

Temozolomide for the treatment of metastatic melanoma. Curr Oncol (2007) 1.13

Induction of reparative dentine formation in monkeys by recombinant human osteogenic protein-1. Arch Oral Biol (1993) 1.12

Bone morphogenetic protein-7 enhances dendritic growth and receptivity to innervation in cultured hippocampal neurons. Eur J Neurosci (2000) 1.11

Utility of adjuvant systemic therapy in melanoma. Ann Oncol (2009) 1.10

Hepatoid adenocarcinoma of the lung: report of a case of an unusual alpha-fetoprotein-producing lung tumor. Am J Surg Pathol (1997) 1.10

Efficacy of high dose intravenous heparin for treatment of left ventricular thrombi with high embolic risk. J Am Coll Cardiol (1994) 1.09

Dissociation between exertional symptoms and circulatory function in patients with heart failure. Circulation (1995) 1.06

Selective induction of apoptosis through activation of caspase-8 in human leukemia cells (Jurkat) by dandelion root extract. J Ethnopharmacol (2010) 1.02

EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration. J Cell Physiol (1989) 1.00

Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol (1994) 0.99

Adoptive immunotherapy in patients with recurrent malignant glioma: preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes. Neurosurg Focus (2000) 0.98

Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population. Br J Cancer (1996) 0.96

Immunotherapy of distant metastatic disease. Ann Oncol (2009) 0.96

The German Aortic Valve Registry (GARY): a nationwide registry for patients undergoing invasive therapy for severe aortic valve stenosis. Thorac Cardiovasc Surg (2012) 0.95

The time-course of the induction of reparative dentine formation in monkeys by recombinant human osteogenic protein-1. Arch Oral Biol (1994) 0.94

Assessment of reperfusion of the infarct zone after acute myocardial infarction by serial cardiac troponin T measurements in serum. Br Heart J (1994) 0.94

Increase in the incidence of non-Hodgkin's lymphomas: evidence for a recent sharp increase in France independent of AIDS. Br J Cancer (1994) 0.94

Ductal carcinoma in situ in a 25-year-old man presenting with apparent unilateral gynecomastia. Curr Oncol (2010) 0.93

Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review. Cancer Treat Rev (2008) 0.93

Swimmers' painful shoulder arthroscopic findings and return rate to sports. Scand J Med Sci Sports (2006) 0.93

Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice. J Virol (2009) 0.91

Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab (1995) 0.91

Recurrent post-traumatic anterior shoulder dislocation--open versus arthroscopic repair. Knee Surg Sports Traumatol Arthrosc (1999) 0.90

Immunodetection of the microvillous cytoskeleton molecules villin and ezrin in the parasitophorous vacuole wall of Cryptosporidium parvum (Protozoa: Apicomplexa). Eur J Cell Biol (1999) 0.89

First-line bevacizumab-containing therapy for breast cancer: results in patients aged≥70 years treated in the ATHENA study. Ann Oncol (2011) 0.89

Blastic plasmacytoid dendritic cell neoplasm in an elderly woman. Med J Malaysia (2013) 0.89

Haematodermic CD4+CD56+ neoplasm: complete remission after methotrexate-asparaginase treatment. Clin Exp Dermatol (2009) 0.89

Delayed surgical removal of a guide-wire fragment following coronary angioplasty. Thorac Cardiovasc Surg (1990) 0.88

OP-1 enhances dendritic growth from cerebral cortical neurons in vitro. Exp Neurol (1999) 0.88

Radiotherapy of advanced mycosis fungoides: indications and results of total skin electron beam and photon beam irradiation. Radiother Oncol (2000) 0.88

Organisational standards for the delivery of intensity-modulated radiation therapy in Ontario. Clin Oncol (R Coll Radiol) (2008) 0.88

[Cutaneous plasmacytoma: review of the literature apropos of a case]. Rev Med Interne (1991) 0.87

Effect of acute hypoxemia on brain blood flow and oxygen metabolism in immature fetal sheep. Am J Physiol (1990) 0.87

Intracisternal osteogenic protein-1 enhances functional recovery following focal stroke. Neuroreport (1998) 0.87

The efficacy of dandelion root extract in inducing apoptosis in drug-resistant human melanoma cells. Evid Based Complement Alternat Med (2010) 0.86

Left ventricular adaptation after atrial septal defect closure assessed by increased concentrations of N-terminal pro-brain natriuretic peptide and cardiac magnetic resonance imaging in adult patients. Heart (2005) 0.85

Cerebral blood flow, oxygenation, and carbohydrate metabolism in immature fetal sheep in utero. Am J Physiol (1989) 0.85

Differential binding, biological and biochemical actions of recombinant PDGF AA, AB, and BB molecules on connective tissue cells. J Cell Physiol (1991) 0.85

Single-agent interleukin-2 in the treatment of metastatic melanoma. Curr Oncol (2007) 0.85

Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction. J Thromb Haemost (2009) 0.85

Comparison of saruplase and alteplase in acute myocardial infarction. SESAM Study Group. The Study in Europe with Saruplase and Alteplase in Myocardial Infarction. Am J Cardiol (1997) 0.85

A new method for exact three-dimensional reconstructions of diatom frustules. J Microsc (2012) 0.84

Percutaneous closure of secundum atrial septal defect with a new self centering device ("angel wings"). Heart (1998) 0.82

Clinical outcome of patients treated with an early invasive strategy after out-of-hospital cardiac arrest. J Int Med Res (2011) 0.82

Histopathological method for diagnosis of cryptosporidiosis using monoclonal antibodies. Eur J Clin Microbiol Infect Dis (1990) 0.82

[Cardiopulmonary exercise capacity increases after interventional ASD-closure]. Z Kardiol (2004) 0.82

Sinoaortic denervation in the nonhuman primate. Am J Physiol (1987) 0.82

Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat. J Neurol Sci (1996) 0.82

Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis. Heart (2006) 0.81

Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study. Ann Oncol (2012) 0.81

Aortic baroreceptor deafferentation in the baboon. J Appl Physiol (1985) (1986) 0.81

[Changes in depression, anxiety, and vital exhaustion in patients after ICD implantation. Comparison of clinical subgroups]. Herzschrittmacherther Elektrophysiol (2011) 0.81

[MALT conjunctival lymphoma: how to treat?]. Bull Soc Ophtalmol Fr (1990) 0.79

Value of clonality studies of cutaneous T lymphocytes in the diagnosis and follow-up of patients with mycosis fungoides. J Pathol (1998) 0.79

Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer. Bone Marrow Transplant (2000) 0.79

Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides. Blood (1998) 0.79

Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder. Int J Clin Pharmacol Ther (2006) 0.79

Establishment, cryopreservation, and growth of 11 cell lines prepared from a juvenile Hawaiian monk seal, Monachus schauinslandi. Methods Cell Sci (2000) 0.79

High-dose chemotherapy and hematopoietic stem cell transplantation for breast cancer: past or future? Semin Oncol (2001) 0.79

[Effect of the imidazoline receptor agonist moxonidine on hemodynamics, coronary circulation, metabolic ischemia markers and the neurohumoral system in patients with essential hypertension. Effects of moxonidine on coronary circulation]. Z Kardiol (2001) 0.79

The effect of bone drilling on pain in gonarthrosis. Int Orthop (1995) 0.79

Treatment of in-stent restenosis with sirolimus-eluting-stents -- a six month clinical and angiographic follow-up. Z Kardiol (2005) 0.78

Changing trends in the incidence of non-Hodgkin's lymphoma in Europe. Biomed Study Group. Ann Oncol (1997) 0.78

Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II). Heart (2009) 0.78

Transcatheter closure of a ruptured ventricular septum after myocardial infarction using a venous approach. Z Kardiol (2005) 0.78

[Injuries in swimmers. Locomotor system injuries in competitive swimmers]. Ugeskr Laeger (1990) 0.78

Recanalization of total coronary occlusions using a laser guidewire (the European TOTAL Surveillance Study). Am J Cardiol (1997) 0.78

Reconstruction of the anterior cruciate ligament with the iliotibial band autograft in patients with chronic knee instability. Knee Surg Sports Traumatol Arthrosc (2001) 0.78

Transdentinal stimulation of reparative dentine formation by osteogenic protein-1 in monkeys. Arch Oral Biol (1995) 0.78

Arthroscopic repair of the bucket-handle meniscus. 10 failures in 27 stable knees followed for 3 years. Acta Orthop Scand (1993) 0.78

Release pattern of N-terminal pro B-type natriuretic peptide (NT-proBNP) in acute coronary syndromes. Clin Res Cardiol (2006) 0.78

Pharmacodynamic modelling of the analgesic effects of piritramide in postoperative patients. Acta Anaesthesiol Scand (1997) 0.77

Retrograde, transsubclavian implantation of a SAPIEN XT™ aortic valve prosthesis with the Edwards NovaFlex+™ system. Clin Res Cardiol (2012) 0.77

Prehospital testing for troponin T in patients with suspected acute myocardial infarction. Am Heart J (1999) 0.77